本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Forte BioSciences Inc

31.43
+0.15000.48%
盤後31.430.00000.00%17:36 EDT
成交量:20.18萬
成交額:618.16萬
市值:6.16億
市盈率:-6.67
高:31.57
開:30.91
低:29.76
收:31.28
52周最高:35.80
52周最低:4.90
股本:1,959.56萬
流通股本:1,651.21萬
量比:0.21
換手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-4.7137
每股收益(LYR):-12.1671
淨資產收益率:-122.28%
總資產收益率:-61.19%
市淨率:10.10
市盈率(LYR):-2.58

資料載入中...

2023/01/12

重要事件披露

8-K - Current report
2022/11/14

重要事件披露

8-K - Current report
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/24

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/15

重要事件披露

8-K - Current report
2022/08/12

重要事件披露

8-K - Current report
2022/08/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/04

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/08/01

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/07/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/12

重要事件披露

8-K - Current report
2022/07/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/05

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/06/24

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/06/07

重要事件披露

8-K - Current report